Pediatric Drugs

Adis, Springer Healthcare

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Pediatric Drugs is a journal published by Adis, Springer Healthcare in New Zealand. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Adis, Springer Healthcare
ISSN
1174-5878 · 1179-2019
Country
New Zealand
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1999-01-01
  • PUBMED · 2010-04-01
Indexing
MEDLINE · PUBMED
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
119 days received→accepted — computed from PubMed (n=59)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1561

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

86

i10-index

933

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
84%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Pediatric drugs
Source type
journal
NLM unique ID (PubMed)
100883685
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pediatric Pain Management Techniques
  • Pediatric Pain Management Techniques
  • Antibiotics Pharmacokinetics and Efficacy
  • Autoimmune and Inflammatory Disorders Research
  • Autoimmune and Inflammatory Disorders Research
Show all subjects (75)
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • Autoimmune and Inflammatory Disorders Research
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Neonatal Respiratory Health Research
  • Neonatal Respiratory Health Research
  • Pediatric Pain Management Techniques
  • Anesthesia and Pain Management
  • Anesthesia and Sedative Agents
  • Antibiotics Pharmacokinetics and Efficacy
  • Attention Deficit Hyperactivity Disorder
  • Antibiotics Pharmacokinetics and Efficacy
  • Anesthesia and Sedative Agents
  • Attention Deficit Hyperactivity Disorder
  • Anesthesia and Sedative Agents
  • Pharmacological Effects and Toxicity Studies
  • Pharmacological Effects and Toxicity Studies
  • Respiratory and Cough-Related Research
  • Respiratory and Cough-Related Research
  • Epilepsy research and treatment
  • Attention Deficit Hyperactivity Disorder
  • Epilepsy research and treatment
  • Epilepsy research and treatment
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacological Effects and Toxicity Studies
  • Acute Lymphoblastic Leukemia research
  • Bacterial Infections and Vaccines
  • Bacterial Infections and Vaccines
  • Bacterial Infections and Vaccines
  • Dermatology and Skin Diseases
  • Anesthesia and Pain Management
  • Gastrointestinal motility and disorders
  • Anesthesia and Pain Management
  • Pregnancy and Medication Impact
  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Gastroesophageal reflux and treatments
  • Gastroesophageal reflux and treatments
  • Anesthesia and Neurotoxicity Research
  • Anesthesia and Neurotoxicity Research
  • Ethics and Legal Issues in Pediatric Healthcare
  • Pharmaceutical Economics and Policy
  • Ethics and Legal Issues in Pediatric Healthcare
  • Pharmaceutical Economics and Policy
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Child and Adolescent Health
  • Respiratory viral infections research
  • Child and Adolescent Health
  • Adolescent and Pediatric Healthcare
  • Rheumatoid Arthritis Research and Therapies
  • Adolescent and Pediatric Healthcare
  • Ethics in Clinical Research
  • Psoriasis: Treatment and Pathogenesis
  • Statistical Methods in Clinical Trials
  • Neonatal Respiratory Health Research
  • HIV/AIDS drug development and treatment
  • Antimicrobial Resistance in Staphylococcus
  • Renal Transplantation Outcomes and Treatments
  • Inflammatory Bowel Disease
  • Antimicrobial Resistance in Staphylococcus
  • Inflammatory Bowel Disease
  • Inflammatory Bowel Disease

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: